80 related articles for article (PubMed ID: 9432685)
1. ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer.
Fu F; Zhang Y; Chen H
Ann Surg Oncol; 2023 Dec; 30(13):8284. PubMed ID: 37755561
[No Abstract] [Full Text] [Related]
2. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
3. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
Wolf M
Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
[TBL] [Abstract][Full Text] [Related]
6. [Bronchial cancer--development, diagnosis, therapy, prognosis].
Zöchbauer S; Krajnik G; Huber H
Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
Eberhardt W
Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
[TBL] [Abstract][Full Text] [Related]
8. [With reference to later intra-/extrathoracic recurrence manifestations also after so-called radical operation: when are (neo-)adjuvant measures indicated?].
Drings P
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():805-9. PubMed ID: 9101994
[TBL] [Abstract][Full Text] [Related]
9. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
10. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]